Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 365

1.

Programming Pacemakers to Reduce and Terminate Atrial Fibrillation.

Pujol-López M, San Antonio R, Tolosana JM, Mont L.

Curr Cardiol Rep. 2019 Sep 13;21(10):127. doi: 10.1007/s11886-019-1214-9. Review.

PMID:
31520271
2.

Endurance training in young athletes: What happens in childhood, stays in childhood?

Guasch E, Mont L.

Eur J Prev Cardiol. 2019 Aug 19:2047487319871649. doi: 10.1177/2047487319871649. [Epub ahead of print] No abstract available.

PMID:
31426670
3.

Aortic remodelling induced by obstructive apneas is normalized with mesenchymal stem cells infusion.

Rubies C, Dantas AP, Batlle M, Torres M, Farre R, Sangüesa G, Montserrat JM, Mont L, Almendros I, Guasch E.

Sci Rep. 2019 Aug 7;9(1):11443. doi: 10.1038/s41598-019-47813-1.

4.

Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence.

Bertaglia E, Blank B, Blomström-Lundqvist C, Brandes A, Cabanelas N, Dan GA, Dichtl W, Goette A, de Groot JR, Lubinski A, Marijon E, Merkely B, Mont L, Piorkowski C, Sarkozy A, Sulke N, Vardas P, Velchev V, Wichterle D, Kirchhof P.

Europace. 2019 Oct 1;21(10):1459-1467. doi: 10.1093/europace/euz172.

5.

Exercise and atrial fibrillation: how health turns harm, and how to turn it back.

Tirapu L, San Antonio R, Tolosana JM, Roca-Luque I, Mont L, Guasch E.

Minerva Cardioangiol. 2019 Oct;67(5):411-424. doi: 10.23736/S0026-4725.19.04998-3. Epub 2019 Jul 24.

PMID:
31343147
6.

Frequent premature ventricular complexes and normal ejection fraction: to treat or not to treat?

Roca-Luque I, Mont L.

Heart. 2019 Sep;105(18):1386-1387. doi: 10.1136/heartjnl-2019-315303. Epub 2019 Jul 4. No abstract available.

PMID:
31273027
7.

Axl expression is increased in early stages of left ventricular remodeling in an animal model with pressure-overload.

Batlle M, Castillo N, Alcarraz A, Sarvari S, Sangüesa G, Cristóbal H, García de Frutos P, Sitges M, Mont L, Guasch E.

PLoS One. 2019 Jun 10;14(6):e0217926. doi: 10.1371/journal.pone.0217926. eCollection 2019.

8.

Management of anticoagulation in patients undergoing leadless pacemaker implantation.

Antonio RS, Chipa-Ccasani F, Apolo J, Linhart M, Trotta O, Pujol-López M, Niebla M, Alarcón F, Trucco E, Arbelo E, Roca-Luque I, Guasch E, Brugada J, Mont L, Tolosana JM.

Heart Rhythm. 2019 May 22. pii: S1547-5271(19)30457-6. doi: 10.1016/j.hrthm.2019.05.016. [Epub ahead of print]

PMID:
31125672
9.

Diagnosis-to-ablation time in atrial fibrillation: A modifiable factor relevant to clinical outcome.

Bisbal F, Alarcón F, Ferrero-De-Loma-Osorio A, González-Ferrer JJ, Alonso-Martín C, Pachón M, Vallés E, Cabanas-Grandío P, Sanchez M, Benito E, Sarrias A, Ruiz-Granell R, Pérez-Villacastín J, Viñolas X, Arias MA, Martí-Almor J, García-Campo E, Fernández-Lozano I, Villuendas R, Mont L.

J Cardiovasc Electrophysiol. 2019 Sep;30(9):1483-1490. doi: 10.1111/jce.14000. Epub 2019 Jun 6.

PMID:
31115940
10.

Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset.

Chua W, Easter CL, Guasch E, Sitch A, Casadei B, Crijns HJGM, Haase D, Hatem S, Kääb S, Mont L, Schotten U, Sinner MF, Hemming K, Deeks JJ, Kirchhof P, Fabritz L.

BMC Cardiovasc Disord. 2019 May 21;19(1):120. doi: 10.1186/s12872-019-1105-4.

11.

International expert consensus on a scientific approach to training novice cardiac resynchronization therapy implanters using performance quality metrics.

Mascheroni J, Mont L, Stockburger M, Patwala A, Retzlaff H, Gallagher AG; CRT-PROBIT group.

Int J Cardiol. 2019 Aug 15;289:63-69. doi: 10.1016/j.ijcard.2019.04.036. Epub 2019 Apr 12.

PMID:
31088758
12.

Safety and usefulness of a second Micra transcatheter pacemaker implantation after battery depletion.

Sánchez P, Apolo J, San Antonio R, Guasch E, Mont L, Tolosana JM.

Europace. 2019 Jun 1;21(6):885. doi: 10.1093/europace/euz064. No abstract available.

PMID:
31081506
13.

Electrocardiographic optimization techniques in resynchronization therapy.

Pujol-López M, San Antonio R, Mont L, Trucco E, Tolosana JM, Arbelo E, Guasch E, Heist EK, Singh JP.

Europace. 2019 Sep 1;21(9):1286-1296. doi: 10.1093/europace/euz126.

PMID:
31038177
14.

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.

Hohnloser SH, Camm J, Cappato R, Diener HC, Heidbüchel H, Mont L, Morillo CA, Abozguia K, Grimaldi M, Rauer H, Reimitz PE, Smolnik R, Mönninghoff C, Kautzner J.

Eur Heart J. 2019 Sep 21;40(36):3013-3021. doi: 10.1093/eurheartj/ehz190. Erratum in: Eur Heart J. 2019 Sep 21;40(36):3043.

15.

EHRA White Paper: knowledge gaps in arrhythmia management-status 2019.

Goette A, Auricchio A, Boriani G, Braunschweig F, Terradellas JB, Burri H, Camm AJ, Crijns H, Dagres N, Deharo JC, Dobrev D, Hatala R, Hindricks G, Hohnloser SH, Leclercq C, Lewalter T, Lip GYH, Merino JL, Mont L, Prinzen F, Proclemer A, Pürerfellner H, Savelieva I, Schilling R, Steffel J, van Gelder IC, Zeppenfeld K, Zupan I, Heidbüchel H; ESC Scientific Document Group .

Europace. 2019 Jul 1;21(7):993-994. doi: 10.1093/europace/euz055.

PMID:
30882143
16.

Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort.

Heidbuchel H, Willems R, Jordaens L, Olshansky B, Carre F, Lozano IF, Wilhelm M, Müssigbrodt A, Huybrechts W, Morgan J, Anfinsen OG, Prior D, Mont L, Mairesse GH, Boveda S, Duru F, Kautzner J, Viskin S, Geelen P, Cygankiewicz I, Hoffmann E, Vandenberghe K, Cannom D, Lampert R.

Eur J Prev Cardiol. 2019 May;26(7):764-775. doi: 10.1177/2047487319834852. Epub 2019 Feb 27.

PMID:
30813818
17.

Failure-free survival of the Riata implantable cardioverter-defibrillator lead after a very long-term follow-up.

San Antonio R, Guasch E, Chipa-Ccasani F, Apolo J, Pujol-López M, Fernández H, Trotta O, Niebla M, Borràs R, Trucco E, Arbelo E, Roca-Luque I, Brugada J, Mont L, Tolosana JM.

Indian Pacing Electrophysiol J. 2019 Jul - Aug;19(4):140-144. doi: 10.1016/j.ipej.2019.02.005. Epub 2019 Feb 19.

18.

Thoracoscopic maze: yes, we can, but should we?

Mont L.

Europace. 2019 Jun 1;21(6):838-839. doi: 10.1093/europace/euz014. No abstract available.

PMID:
30753413
19.

Thoracoscopic vs. catheter ablation for atrial fibrillation: long-term follow-up of the FAST randomized trial.

Castellá M, Kotecha D, van Laar C, Wintgens L, Castillo Y, Kelder J, Aragon D, Nuñez M, Sandoval E, Casellas A, Mont L, van Boven WJ, Boersma LVA, van Putte BP.

Europace. 2019 May 1;21(5):746-753. doi: 10.1093/europace/euy325.

20.

Reproducibility and accuracy of late gadolinium enhancement cardiac magnetic resonance measurements for the detection of left atrial fibrosis in patients undergoing atrial fibrillation ablation procedures.

Mărgulescu AD, Nuñez-Garcia M, Alarcón F, Benito EM, Enomoto N, Cozzari J, Chipa F, Fernandez H, Borras R, Guasch E, Butakoff C, Tolosana JM, Arbelo E, Camara O, Mont L.

Europace. 2019 May 1;21(5):724-731. doi: 10.1093/europace/euy314.

21.

Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial.

Boriani G, Pieragnoli P, Botto GL, Puererfellner H, Mont L, Ziacchi M, Manolis AS, Gulizia M, Tukkie R, Landolina M, Ricciardi G, Cicconelli M, Grammatico A, Biffi M.

Europace. 2019 Apr 1;21(4):636-644. doi: 10.1093/europace/euy286.

PMID:
30649270
22.

Delayed Gadolinium Enhancement Magnetic Resonance Imaging Detected Anatomic Gap Length in Wide Circumferential Pulmonary Vein Ablation Lesions Is Associated With Recurrence of Atrial Fibrillation.

Linhart M, Alarcon F, Borràs R, Benito EM, Chipa F, Cozzari J, Caixal G, Enomoto N, Carlosena A, Guasch E, Arbelo E, Tolosana JM, Prat-Gonzalez S, Perea RJ, Doltra A, Sitges M, Brugada J, Berruezo A, Mont L.

Circ Arrhythm Electrophysiol. 2018 Dec;11(12):e006659. doi: 10.1161/CIRCEP.118.006659.

PMID:
30562102
23.

T-wave inversion in young athletes: Should we check their bones or their identity card? The quest for precision medicine.

Guasch E, Sanz-de la Garza M, Mont L.

Eur J Prev Cardiol. 2019 Apr;26(6):638-640. doi: 10.1177/2047487318820665. Epub 2018 Dec 13. No abstract available.

PMID:
30545251
24.

Mini-electrodes help identifying hidden slow conduction during ventricular tachycardia substrate ablation.

Soto-Iglesias D, Andreu D, Jáuregui B, Linhart M, Mont L, Berruezo A.

J Electrocardiol. 2018 Nov - Dec;51(6):1011-1013. doi: 10.1016/j.jelectrocard.2018.08.016. Epub 2018 Aug 13.

PMID:
30497721
25.

Determining the best approach to reduce the impact of exercise-induced atrial fibrillation: prevention, screening, or symptom-based treatment?

San Antonio R, Guasch E, Tolosana JM, Mont L.

Expert Rev Cardiovasc Ther. 2019 Jan;17(1):19-29. doi: 10.1080/14779072.2019.1550720. Epub 2018 Dec 3. Review.

PMID:
30451034
26.

ACE2 and ACE in acute and chronic rejection after human heart transplantation.

Soler MJ, Batlle M, Riera M, Campos B, Ortiz-Perez JT, Anguiano L, Roca-Ho H, Farrero M, Mont L, Pascual J, Perez-Villa F.

Int J Cardiol. 2019 Jan 15;275:59-64. doi: 10.1016/j.ijcard.2018.10.002. Epub 2018 Oct 3.

PMID:
30314840
27.

Influence of myocardial scar on the response to frequent premature ventricular complex ablation.

Penela D, Martínez M, Fernández-Armenta J, Aguinaga L, Tercedor L, Ordóñez A, Acosta J, Martí-Almor J, Bisbal F, Rossi L, Borràs R, Linhart M, Soto-Iglesias D, Jáuregui B, Ortiz-Pérez JT, Perea RJ, Bosch X, Mont L, Berruezo A.

Heart. 2019 Mar;105(5):378-383. doi: 10.1136/heartjnl-2018-313452. Epub 2018 Sep 21.

PMID:
30242139
28.

A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS.

Brignole M, Pokushalov E, Pentimalli F, Palmisano P, Chieffo E, Occhetta E, Quartieri F, Calò L, Ungar A, Mont L; APAF-CRT Investigators.

Eur Heart J. 2018 Dec 1;39(45):3999-4008. doi: 10.1093/eurheartj/ehy555.

PMID:
30165479
29.

Prediction of premature ventricular complex origin in left vs. right ventricular outflow tract: a novel anatomical imaging approach.

Korshunov V, Penela D, Linhart M, Acosta J, Martinez M, Soto-Iglesias D, Fernández-Armenta J, Vassanelli F, Cabrera M, Borràs R, Jáuregui B, Ortiz-Pérez JT, Perea RJ, Bosch X, Sanchez-Quintana D, Mont L, Berruezo A.

Europace. 2019 Jan 1;21(1):147-153. doi: 10.1093/europace/euy162.

PMID:
30016418
30.

In-vivo compatibility between pacemakers and dental equipment.

Conde-Mir I, Miranda-Rius J, Trucco E, Lahor-Soler E, Brunet-Llobet L, Domingo R, Tolosana JM, Mont L.

Eur J Oral Sci. 2018 Aug;126(4):307-315. doi: 10.1111/eos.12534. Epub 2018 Jul 4.

PMID:
29972599
31.

European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS).

Boriani G, Fauchier L, Aguinaga L, Beattie JM, Blomstrom Lundqvist C, Cohen A, Dan GA, Genovesi S, Israel C, Joung B, Kalarus Z, Lampert R, Malavasi VL, Mansourati J, Mont L, Potpara T, Thornton A, Lip GYH; ESC Scientific Document Group .

Europace. 2019 Jan 1;21(1):7-8. doi: 10.1093/europace/euy110. No abstract available.

PMID:
29905786
32.

VT ablation and survival: A solved question?

Penela D, Mont L.

Int J Cardiol. 2018 Sep 15;267:118-119. doi: 10.1016/j.ijcard.2018.05.125. Epub 2018 Jun 2. No abstract available.

PMID:
29885831
33.

Cardiac magnetic resonance based ablation procedures: ready for take-off?

Sommer P, Mont L.

Europace. 2019 Jan 1;21(1):5-6. doi: 10.1093/europace/euy136. No abstract available.

PMID:
29878106
34.

Preferential regional distribution of atrial fibrosis in posterior wall around left inferior pulmonary vein as identified by late gadolinium enhancement cardiac magnetic resonance in patients with atrial fibrillation.

Benito EM, Cabanelas N, Nuñez-Garcia M, Alarcón F, Figueras I Ventura RM, Soto-Iglesias D, Guasch E, Prat-Gonzalez S, Perea RJ, Borràs R, Butakoff C, Camara O, Bisbal F, Arbelo E, Tolosana JM, Brugada J, Berruezo A, Mont L.

Europace. 2018 Dec 1;20(12):1959-1965. doi: 10.1093/europace/euy095.

35.

Response to the letter to the editor on "Impact of left atrial volume, sphericity, and fibrosis on the outcome of catheter ablation for atrial fibrillation".

den Uijl DW, Mont L.

J Cardiovasc Electrophysiol. 2018 Jul;29(7):E15. doi: 10.1111/jce.13634. Epub 2018 Jun 8. No abstract available.

PMID:
29777558
36.

Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: Results from the Micra atrioventricular feasibility studies.

Chinitz L, Ritter P, Khelae SK, Iacopino S, Garweg C, Grazia-Bongiorni M, Neuzil P, Johansen JB, Mont L, Gonzalez E, Sagi V, Duray GZ, Clementy N, Sheldon T, Splett V, Stromberg K, Wood N, Steinwender C.

Heart Rhythm. 2018 Sep;15(9):1363-1371. doi: 10.1016/j.hrthm.2018.05.004. Epub 2018 May 11.

37.

Improvement of Reverse Remodeling Using Electrocardiogram Fusion-Optimized Intervals in Cardiac Resynchronization Therapy: A Randomized Study.

Trucco E, Tolosana JM, Arbelo E, Doltra A, Castel MÁ, Benito E, Borràs R, Guasch E, Vidorreta S, Vidal B, Montserrat S, Sitges M, Berruezo A, Brugada J, Mont L.

JACC Clin Electrophysiol. 2018 Feb;4(2):181-189. doi: 10.1016/j.jacep.2017.11.020. Epub 2018 Feb 1.

38.

Postprocedural LGE-CMR comparison of laser and radiofrequency ablation lesions after pulmonary vein isolation.

Figueras I Ventura RM, Mǎrgulescu AD, Benito EM, Alarcón F, Enomoto N, Prat-Gonzalez S, Perea RJ, Borràs R, Chipa F, Arbelo E, Tolosana JM, Brugada J, Berruezo A, Mont L.

J Cardiovasc Electrophysiol. 2018 Aug;29(8):1065-1072. doi: 10.1111/jce.13616. Epub 2018 May 21.

PMID:
29722466
39.

Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.

Hohnloser SH, Camm J, Cappato R, Diener HC, Heidbuchel H, Lanz HJ, Mont L, Morillo CA, Smolnik R, Yin OQP, Kautzner J.

Clin Cardiol. 2018 Apr;41(4):440-449. doi: 10.1002/clc.22918. Epub 2018 Apr 17.

40.

Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF study.

Bisbal F, Alarcón F, Ferrero-de-Loma-Osorio A, González-Ferrer JJ, Alonso C, Pachón M, Tizón H, Cabanas-Grandío P, Sanchez M, Benito E, Teis A, Ruiz-Granell R, Pérez-Villacastín J, Viñolas X, Arias MA, Vallés E, García-Campo E, Fernández-Lozano I, Villuendas R, Mont L.

Eur Heart J Cardiovasc Imaging. 2018 Sep 1;19(9):1002-1009. doi: 10.1093/ehjci/jey060. Erratum in: Eur Heart J Cardiovasc Imaging. 2018 Sep 1;19(9):1075.

41.

Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation.

Kirchhof P, Haeusler KG, Blank B, De Bono J, Callans D, Elvan A, Fetsch T, Van Gelder IC, Gentlesk P, Grimaldi M, Hansen J, Hindricks G, Al-Khalidi HR, Massaro T, Mont L, Nielsen JC, Nölker G, Piccini JP, De Potter T, Scherr D, Schotten U, Themistoclakis S, Todd D, Vijgen J, Di Biase L.

Eur Heart J. 2018 Aug 21;39(32):2942-2955. doi: 10.1093/eurheartj/ehy176.

42.

Impact of left atrial volume, sphericity, and fibrosis on the outcome of catheter ablation for atrial fibrillation.

den Uijl DW, Cabanelas N, Benito EM, Figueras R, Alarcón F, Borràs R, Prat S, Guasch E, Perea R, Sitges M, Brugada J, Berruezo A, Mont L.

J Cardiovasc Electrophysiol. 2018 May;29(5):740-746. doi: 10.1111/jce.13482. Epub 2018 Apr 6.

PMID:
29528532
43.

Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design : The ASAF trial: ablation of sympathetic atrial fibrillation.

de Jong MR, Hoogerwaard AF, Adiyaman A, Smit JJJ, Ramdat Misier AR, Heeg JE, van Hasselt BAAM, Van Gelder IC, Crijns HJGM, Lozano IF, Toquero Ramos JE, Javier Alzueta F, Ibañez B, Rubio JM, Arribas F, Porres Aracama JM, Brugada J, Mont L, Elvan A.

Clin Res Cardiol. 2018 Jul;107(7):539-547. doi: 10.1007/s00392-018-1214-6. Epub 2018 Feb 27.

PMID:
29487995
44.

Image-based criteria to identify the presence of epicardial arrhythmogenic substrate in patients with transmural myocardial infarction.

Soto-Iglesias D, Acosta J, Penela D, Fernández-Armenta J, Cabrera M, Martínez M, Vassanelli F, Alcaine A, Linhart M, Jáuregui B, Efimova E, Perea RJ, Prat-González S, Ortiz-Pérez JT, Bosch X, Mont L, Camara O, Berruezo A.

Heart Rhythm. 2018 Jun;15(6):814-821. doi: 10.1016/j.hrthm.2018.02.007. Epub 2018 Feb 7.

PMID:
29427821
45.

Selection of the Best of 2017 in Catheter Ablation.

Benito EM, Mont L.

Rev Esp Cardiol (Engl Ed). 2018 Apr;71(4):303-304. doi: 10.1016/j.rec.2017.12.010. Epub 2018 Feb 13. English, Spanish. No abstract available.

PMID:
29422269
46.

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know.

Guasch E, Mont L, Sitges M.

Neth Heart J. 2018 Mar;26(3):133-145. doi: 10.1007/s12471-018-1080-x. Review.

47.

Validity of the Polar V800 monitor for measuring heart rate variability in mountain running route conditions.

Caminal P, Sola F, Gomis P, Guasch E, Perera A, Soriano N, Mont L.

Eur J Appl Physiol. 2018 Mar;118(3):669-677. doi: 10.1007/s00421-018-3808-0. Epub 2018 Jan 22.

48.

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference.

Kotecha D, Breithardt G, Camm AJ, Lip GYH, Schotten U, Ahlsson A, Arnar D, Atar D, Auricchio A, Bax J, Benussi S, Blomstrom-Lundqvist C, Borggrefe M, Boriani G, Brandes A, Calkins H, Casadei B, Castellá M, Chua W, Crijns H, Dobrev D, Fabritz L, Feuring M, Freedman B, Gerth A, Goette A, Guasch E, Haase D, Hatem S, Haeusler KG, Heidbuchel H, Hendriks J, Hunter C, Kääb S, Kespohl S, Landmesser U, Lane DA, Lewalter T, Mont L, Nabauer M, Nielsen JC, Oeff M, Oldgren J, Oto A, Pison L, Potpara T, Ravens U, Richard-Lordereau I, Rienstra M, Savelieva I, Schnabel R, Sinner MF, Sommer P, Themistoclakis S, Van Gelder IC, Vardas PE, Verma A, Wakili R, Weber E, Werring D, Willems S, Ziegler A, Hindricks G, Kirchhof P.

Europace. 2018 Mar 1;20(3):395-407. doi: 10.1093/europace/eux318.

49.

Inappropriate Shock Due to Air Entrapment in the Pocket of a Subcutaneous Implantable Cardioverter-defibrillator.

Linhart M, Tolosana JM, Chipa F, Trucco E, Mont L.

Rev Esp Cardiol (Engl Ed). 2019 Jan;72(1):79-81. doi: 10.1016/j.rec.2017.10.026. Epub 2017 Dec 13. English, Spanish. No abstract available.

PMID:
29246807
50.

Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.

Hernandez-Ojeda J, Arbelo E, Borras R, Berne P, Tolosana JM, Gomez-Juanatey A, Berruezo A, Campuzano O, Sarquella-Brugada G, Mont L, Brugada R, Brugada J.

J Am Coll Cardiol. 2017 Oct 17;70(16):1991-2002. doi: 10.1016/j.jacc.2017.08.029.

Supplemental Content

Support Center